US Patent Issued to BeOne Medicines | on Sept. 1 for "5-amino-6,8-dihydro-1H-furo[3,4-dpyrrolo[3,2-bpyridine-2-carboxamide derivatives as MTA-cooperative inhibitors of PRMT5" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,048, issued on Sept. 1, was assigned to BeOne Medicines | GmbH (Basel, Switzerland).

"5-amino-6,8-dihydro-1H-furo[3,4-dpyrrolo[3,2-bpyridine-2-carboxamide derivatives as MTA-cooperative inhibitors of PRMT5" was invented by Jing Li (Beijing), Sanjia Xu (Beijing), Yian Guo (Beijing) and Zhiwei Wang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides 5-amino-6,8-dihydro-1H-furo[3,4-d]pyrrolo[3,2-b]pyridine-2-carboxamide derivatives, the use thereof for selectively inhibiting the activity of PRMT5 in cooperation with MTA in tumors bearing MTAPDEL mutation, and pharmaceutical compositions comprising the compounds, e.g., for t...